The night the "hottest band in the world" had to hide out in Midland after their infamous 1974 Delta College concert.

The NHL Global Series returns this week in Stockholm, Sweden, but first, the Hockey Hall of Fame Class of 2025 will ...

The recently announced Grand Valley State and Michigan Central partnership will offer pathways for middle and high schoolers to get credentials and four-year degree opportunities.

For us motorcycle nerds, the best time of the year is here. Long-awaited launches, exciting concepts, and ambitious two-wheelers adorn events like EICMA, the Tokyo Motor Show, and CIMA Motor, among ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Asset manager Altered Space has secured the letting of a 24,000 sq ft unit to the gym on a 15-year lease, meaning the square is now fully occupied. The unit was previously a Wilko but will now host a ...

Okay. Great. I'm Max Skor, a biotech analyst with Morgan Stanley. I'm happy to be hosting Amicus Therapeutics. With us today is Sébastien Martel, Chief Business Officer; Jeffrey Castelli, Chief ...

As operations adopt more efficient solutions, these figures could change. To reflect this uncertainty, the report presented three possible scenarios. Under these, AI's water use could vary between 637 ...

The report noted that while water use for cooling data centres is widely acknowledged, the indirect water use through electricity generation remains underappreciated. AI's broader water footprint also ...

Amicus Therapeutics, Inc. (NASDAQ:FOLD) is one of the best biotech stocks to buy according to billionaire Steve Cohen. On July 17, Morgan Stanley upgraded FOLD to Overweight with a $12 price target, ...

Amicus Therapeutics, Inc. (NASDAQ:FOLD) is one of the best biotech stocks to buy according to billionaire Steve Cohen. On July 17, Morgan Stanley upgraded FOLD to Overweight with a $12 price target, ...

Amicus Therapeutics (NASDAQ:FOLD) traded higher on Thursday after Morgan Stanley upgraded the stock, citing a favorable setup for the company ahead of a key ruling in its patent dispute with generic ...